Fingerprint
Dive into the research topics of 'Astegolimab or Efmarodocokin Alfa in Patients with Severe COVID-19 Pneumonia: A Randomized, Phase 2 Trial∗'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Astegolimab or Efmarodocokin Alfa in Patients with Severe COVID-19 Pneumonia: A Randomized, Phase 2 Trial∗
Michael Waters, James A. McKinnell, Andre C. Kalil, Greg S. Martin, Timothy G. Buchman, Wiebke Theess, Xiaoying Yang, Annemarie N. Lekkerkerker, Tracy Staton, Carrie M. Rosenberger, Rajita Pappu, Yehong Wang, Wenhui Zhang, Logan Brooks, Dorothy Cheung, Joshua Galanter, Hubert Chen, Divya Mohan, Melicent C. Peck*
*Corresponding author for this work
Research output: Contribution to journal › Article › peer-review
10
Scopus
citations